Latest Foundation Fighting Blindness Stories
A new gene therapy method developed by University of Florida researchers has the potential to treat a common form of blindness that strikes both youngsters and adults.
OXFORD, England, June 22, 2011 /PRNewswire/ -- - RetinoStat(R) Progress in Phase I Study in Wet Age-Related Macular Degeneration Oxford BioMedica plc ("Oxford BioMedica" or "the Company") (LSE: OXB), a leading gene therapy company, today announces that the first dose level of RetinoStat(R) is safe and well-tolerated at one month following treatment. RetinoStat(R) is a novel gene-based treatment for neovascular "wet" age-related macular degeneration (AMD), designed and...
The first two patients with common but incurable diseases of the eye that can lead to blindness have been enrolled early in a two phase groundbreaking clinical trial of therapy that researchers are hoping will heal the damage caused by the conditions.
The Foundation Fighting Blindness, a national nonprofit that drives eyesight-saving research, will honor Ophthalmologist and Virginia Eye Institute Founder Anthony D. Sakowski, Jr., M.D., F.A.C.S., at the Richmond Dining in the Dark event.
The Foundation Fighting Blindness held its 6th annual Vision Walk which took place at Browns Chapel Park in Reston Virginia on Saturday, May 7th.
Slowing down the aggregation or â€œclumpingâ€ of vitamin A in the eye may help prevent vision loss caused by macular degeneration.
Neurobiologists funded by the Office of Naval Research (ONR) have discovered a potential cure for degenerative vision diseases leading to terminal blindness.
Researchers at the University of Massachusetts Medical School (UMMS) believe they may have found a new treatment for retinitis pigmentosa (RP), a severe neurodegenerative disease of the retina that ultimately results in blindness.
Researchers working toward cure for pigmentosa; other retinal diseases.
- An armed gangster.